Ensign Peak Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,466
| Closed | -$251K | – | 1770 |
|
|
2023
Q2 | $251K | Buy |
2,466
+1,143
| +86% | +$116K | ﹤0.01% | 1730 |
|
|
2023
Q1 | $234K | Buy |
1,323
+156
| +13% | +$27.6K | ﹤0.01% | 1734 |
|
|
2022
Q4 | $451K | Buy |
1,167
+498
| +74% | +$193K | ﹤0.01% | 1643 |
|
|
2022
Q3 | $225K | Sell |
669
-92
| -12% | -$30.9K | ﹤0.01% | 1833 |
|
|
2022
Q2 | $250K | Hold |
761
| – | – | ﹤0.01% | 1730 |
|
|
2022
Q1 | $333K | Hold |
761
| – | – | ﹤0.01% | 1714 |
|
|
2021
Q4 | $334K | Hold |
761
| – | – | ﹤0.01% | 1776 |
|
|
2021
Q3 | $423K | Buy |
761
+280
| +58% | +$156K | ﹤0.01% | 1655 |
|
|
2021
Q2 | $247K | Buy |
+481
| New | +$247K | ﹤0.01% | 1696 |
|